Skip to main navigation
For additional product information, please see

Product Information

  • AviseTest.com

Contact Us

  • Contact Us

Social

Exagen Diagnostics - Logo
  • About Exagen
    • Exagen Quality
    • News & Events
    • Lab Certifications
  • Our Products
    • AVISE CTD
      • SLE & Connective Tissue Disease Test
    • AVISE Lupus
      • SLE Diagnostic Test
    • AVISE SLE Monitor
      • SLE Disease Monitoring Test
    • AVISE SLE Prognostic
      • SLE Prognostic Test
    • AVISE APS
      • Antiphospholipid Syndrome Test
    • AVISE MTX
      • Methotrexate Polyglutamate Measuring Test
    • AVISE HCQ
      • The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood
    • AVISE Touch
      • Low volume specimen collection device
    • AVISE Anti-CarP
      • RA Diagnosis & Prognosis
    • AVISE PC4d
      • History of SLE Thrombosis
  • Our People
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • CB-CAPs – Lupus Biomarkers
    • Clinical Trials
    • Research & Development
    • Publications
  • Business Development
    • Business Development
    • Partners
  • Investors

    Investor Relations

    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Investor FAQs
    • Analyst Coverage
    • Investor Contacts
    • Email Alerts
Image

Corporate Governance

Corporate Governance

Governance Documents
Sustainability Report
Code of Conduct
Corporate Governance Guidelines
Audit Committee Charter
Compensation Committee Charter
Nominating and Governance Committee Charter
Print Page
Email Alerts
RSS Feeds
Investor Contacts
© 2021 Exagen Inc. | All Rights Reserved
SA1168

Footer

  • Terms of Use
  • Notice of Privacy Practices
  • Lab Certifications
  • Contact Us

Social

Image

© 2021 Exagen Inc. | All Rights Reserved

SA1168

Footer

  • Terms of Use
  • Notice of Privacy Practices
  • Lab Certifications
  • Contact Us

Social

Exagen Quality Seal
  • About Exagen
    • ← Back
    • Exagen Quality
    • News & Events
    • Lab Certifications
  • Our Products
    • ← Back
    • AVISE CTD
      • ← Back
      • SLE & Connective Tissue Disease Test
    • AVISE Lupus
      • ← Back
      • SLE Diagnostic Test
    • AVISE SLE Monitor
      • ← Back
      • SLE Disease Monitoring Test
    • AVISE SLE Prognostic
      • ← Back
      • SLE Prognostic Test
    • AVISE APS
      • ← Back
      • Antiphospholipid Syndrome Test
    • AVISE MTX
      • ← Back
      • Methotrexate Polyglutamate Measuring Test
    • AVISE HCQ
      • ← Back
      • The Hydroxychloroquine (HCQ) test measuring drug levels in whole blood
    • AVISE Touch
      • ← Back
      • Low volume specimen collection device
    • AVISE Anti-CarP
      • ← Back
      • RA Diagnosis & Prognosis
    • AVISE PC4d
      • ← Back
      • History of SLE Thrombosis
  • Our People
    • ← Back
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • ← Back
    • CB-CAPs – Lupus Biomarkers
    • Clinical Trials
    • Research & Development
    • Publications
  • Business Development
    • ← Back
    • Business Development
    • Partners
  • Investors

    Investor Relations

    • ← Back
    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Investor FAQs
    • Analyst Coverage
    • Investor Contacts
    • Email Alerts